当前位置:首页 - 行情中心 - 三元生物(301206) - 财务分析 - 利润表

三元生物

(301206)

  

流通市值:25.21亿  总市值:49.31亿
流通股本:1.03亿   总股本:2.02亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入351,192,635.35235,313,762.07116,276,458.04674,905,595.63
营业收入351,192,635.35235,313,762.07116,276,458.04674,905,595.63
二、营业总成本395,084,253.43261,019,478.18135,685,668.54582,967,553.58
营业成本349,299,318.9235,035,340.17120,780,885.65580,046,442.92
税金及附加1,934,795.691,212,702.36601,554.623,210,720.64
销售费用3,665,284.792,444,127.3957,856.595,193,766.1
管理费用10,916,484.216,882,274.832,391,191.8616,862,462.37
研发费用36,626,985.6421,561,358.9511,788,523.1834,078,331.05
财务费用-7,358,615.8-6,116,325.43-834,343.36-56,424,169.5
其中:利息收入4,401,728.53,750,180.622,551,480.0813,864,881.12
加:公允价值变动收益----327,000
加:投资收益83,866,978.7856,393,296.1627,779,775.0586,472,128.13
资产减值损失(新)4,184,224.375,164,409.364,103,592.14-5,176,867.29
信用减值损失(新)-109,277.94-46,395.05-104,752.14242,822.1
其他收益821,692.01579,858.67506,858.6612,903,774.52
营业利润平衡项目0000
四、营业利润44,871,999.1436,385,453.0312,876,263.21186,052,899.51
加:营业外收入178,605.82113,959.6103,142251,569.31
减:营业外支出6246246242,349,169.72
利润总额平衡项目0000
五、利润总额45,049,980.9636,498,788.6312,978,781.21183,955,299.1
减:所得税费用3,377,080.393,181,750.695,170,586.6220,268,657.76
六、净利润41,672,900.5733,317,037.947,808,194.59163,686,641.34
持续经营净利润41,672,900.5733,317,037.947,808,194.59163,686,641.34
归属于母公司股东的净利润41,672,900.5733,317,037.947,808,194.59163,686,641.34
(一)基本每股收益0.210.160.040.82
(二)稀释每股收益0.210.160.040.82
九、综合收益总额41,672,900.5733,317,037.947,808,194.59163,686,641.34
归属于母公司股东的综合收益总额41,672,900.5733,317,037.947,808,194.59163,686,641.34
公告日期2023-10-272023-08-312023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑